• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

270 例经贵要静脉行完全植入式静脉输液港放射影像学引导植入术的结果分析。

Outcome analysis in 270 radiologically guided implantations of totally implantable venous access ports via basilic vein.

机构信息

Department of Radiology, Taichung Veterans General Hospital, Taichung, Taiwan, ROC.

Division of Radiology, Everan Hospital, Taichung, Taiwan, ROC.

出版信息

J Chin Med Assoc. 2020 Mar;83(3):295-301. doi: 10.1097/JCMA.0000000000000265.

DOI:10.1097/JCMA.0000000000000265
PMID:31990818
Abstract

BACKGROUND

Totally implantable venous access ports (TIVAPs) are widely applied in patients who require chemotherapy, parenteral nutrition, or frequent intravenous drug infusion. Although various venous access routes are possible for TIVAP insertion, the best method remains a topic of controversy. We present a single-center retrospective study of radiologically guided placement of TIVAPs through the basilic vein, with analysis of technical feasibility, patient safety, and device-related complications.

METHODS

We retrospectively reviewed 270 patients who received TIVAP implantation through the basilic vein from November 2013 to July 2016, under imaging guidance by an interventional radiology team at our institution. Fluoroscopic images, chest radiographs, computed tomography scans, and medical records were reviewed after port implantation. Catheter maintenance days were calculated and catheter-related complications were recorded.

RESULTS

The procedural success rate was 99.3%. In total, 270 TIVAPs were implanted in 270 patients, of which 150 remained functional at the end of the study period. The total catheter maintenance days was 77 543 days, and the mean catheter indwelling duration was 287 ± 207 days. In 20 (7.4%) patients, TIVAP-related complications occurred during the follow-up period, resulting in a postprocedural complication rate of 0.26 incidences per 1000 catheter days. No significant relationship was observed between complications and gender (p = 0.188), age (p = 0.528), body mass index (p = 0.547), the type of primary malignancy (p = 0.914), or between the left and right basilic veins (p = 0.319).

CONCLUSION

Real-time ultrasound and fluoroscopic guidance provides a safe method for TIVAP implantation through the basilic vein, with a high technical success rate and few device-related complications.

摘要

背景

完全植入式静脉输液港(TIVAP)广泛应用于需要化疗、肠外营养或频繁静脉药物输注的患者。尽管 TIVAP 插入有多种静脉入路方式,但最佳方法仍存在争议。我们报告了一项单中心回顾性研究,分析了在影像学引导下经贵要静脉植入 TIVAP 的技术可行性、患者安全性和器械相关并发症。

方法

我们回顾性分析了 2013 年 11 月至 2016 年 7 月期间在我院介入放射科团队的影像学引导下接受经贵要静脉植入 TIVAP 的 270 例患者。在植入后,对患者的荧光透视图像、胸片、CT 扫描和病历进行了回顾。计算了导管留置天数,并记录了导管相关并发症。

结果

手术成功率为 99.3%。共植入 270 个 TIVAP,其中 150 个在研究结束时仍保持功能。总导管留置天数为 77543 天,平均导管留置时间为 287±207 天。在 20 例(7.4%)患者中,在随访期间发生了 TIVAP 相关并发症,导致术后并发症发生率为每 1000 导管日 0.26 例。并发症与性别(p=0.188)、年龄(p=0.528)、体重指数(p=0.547)、原发性恶性肿瘤类型(p=0.914)或左右贵要静脉之间无显著关系(p=0.319)。

结论

实时超声和荧光透视引导为经贵要静脉植入 TIVAP 提供了一种安全的方法,具有较高的技术成功率和较少的器械相关并发症。

相似文献

1
Outcome analysis in 270 radiologically guided implantations of totally implantable venous access ports via basilic vein.270 例经贵要静脉行完全植入式静脉输液港放射影像学引导植入术的结果分析。
J Chin Med Assoc. 2020 Mar;83(3):295-301. doi: 10.1097/JCMA.0000000000000265.
2
Ultrasound-guided totally implantable venous access ports placement via right brachiocephalic vein in pediatric population: A clinical debut.超声引导下经右头臂静脉在儿科人群中完全植入式静脉输液港的置管:临床初探。
Pediatr Blood Cancer. 2022 Oct;69(10):e29911. doi: 10.1002/pbc.29911. Epub 2022 Jul 26.
3
A Comparison Between Upper Arm and Chest for Optimal Site of Totally Implanted Venous Access Ports in Patients with Female Breast Cancer.女性乳腺癌患者完全植入式静脉输液港最佳植入部位:上臂与胸部的比较
Ann Vasc Surg. 2018 Jul;50:128-134. doi: 10.1016/j.avsg.2017.11.059. Epub 2018 Feb 23.
4
Efficacy and safety of ultrasound-guided totally implantable venous access ports via the right innominate vein in adult patients with cancer: Single-centre experience and protocol.超声引导下经右无名静脉置入完全植入式静脉输液港在成人肿瘤患者中的疗效和安全性:单中心经验和方案。
Eur J Surg Oncol. 2019 Feb;45(2):275-278. doi: 10.1016/j.ejso.2018.07.048. Epub 2018 Jul 26.
5
Percutaneous implantation of peripherally inserted totally implantable venous access systems in the forearm in adolescent patients.经皮在前臂植入外周置入的完全植入式静脉输液港系统在青少年患者中的应用。
Pediatr Radiol. 2022 Jul;52(8):1550-1558. doi: 10.1007/s00247-022-05321-x. Epub 2022 Apr 4.
6
Implanting totally implantable venous access ports in the upper arm is feasible and safe for patients with early breast cancer.对于早期乳腺癌患者,在上臂植入全植入式静脉通路端口是可行且安全的。
J Vasc Access. 2020 Sep;21(5):609-614. doi: 10.1177/1129729819894461. Epub 2019 Dec 16.
7
Implanting totally implantable venous access port via the internal jugular vein guided by ultrasonography is feasible and safe in patients with breast cancer.在超声引导下经颈内静脉植入全植入式静脉通路端口对乳腺癌患者是可行且安全的。
World J Surg Oncol. 2014 Dec 8;12:378. doi: 10.1186/1477-7819-12-378.
8
Peripherally placed totally implantable venous-access port systems of the forearm: clinical experience in 763 consecutive patients.前臂外周完全植入式静脉通道端口系统:763 例连续患者的临床经验。
Cardiovasc Intervent Radiol. 2010 Dec;33(6):1159-67. doi: 10.1007/s00270-010-9854-6. Epub 2010 Apr 23.
9
Ultrasound and fluoroscopy-guided placement of central venous ports via internal jugular vein: retrospective analysis of 1254 port implantations at a single center.超声和透视引导下经颈内静脉中央静脉置管:单中心 1254 例置管的回顾性分析。
Korean J Radiol. 2012 May-Jun;13(3):314-23. doi: 10.3348/kjr.2012.13.3.314. Epub 2012 Apr 17.
10
Long-term clinical outcomes of the single-incision technique for implantation of implantable venous access ports via the axillary vein.经腋静脉植入可植入式静脉通路端口单切口技术的长期临床结局
J Vasc Access. 2017 Jul 14;18(4):345-351. doi: 10.5301/jva.5000751. Epub 2017 Jun 23.

引用本文的文献

1
[Clinical Practice and Quality Control Guidelines for Totally Implantable Venous Access Ports in Cancer Patients (2024)].《癌症患者完全植入式静脉输液港临床实践与质量控制指南(2024年)》
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 Mar 20;56(2):400-410. doi: 10.12182/20250360602.
2
A Monocentric Analysis of Implantable Ports in Cancer Treatment: Five-Year Efficacy and Safety Evaluation.癌症治疗中植入式端口的单中心分析:五年疗效与安全性评估
Cancers (Basel). 2024 Aug 9;16(16):2802. doi: 10.3390/cancers16162802.
3
Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review.
肿瘤学中中央静脉通路装置的术语、并发症和移除原因:范围综述。
BMC Cancer. 2024 Apr 19;24(1):498. doi: 10.1186/s12885-024-12099-8.
4
Transesophageal echocardiography-guided implantation of totally implantable venous access devices via the internal jugular vein: retrospective analysis of 297 cases in pediatric patients.经食管超声心动图引导下经颈内静脉植入完全植入式静脉输液港:297 例儿科患者的回顾性分析。
World J Surg Oncol. 2022 Aug 30;20(1):272. doi: 10.1186/s12957-022-02734-8.
5
Catheter allotopia with totally implantable access port: A report of three cases and literature review.带完全植入式接入端口的导管异位:三例报告及文献综述。
Clin Case Rep. 2020 Nov 6;9(1):128-132. doi: 10.1002/ccr3.3479. eCollection 2021 Jan.